Dr. Adam Berger
Claim this profileRutgers Cancer Institute
Studies Melanoma
Studies Skin Cancer
11 reported clinical trials
16 drugs studied
Area of expertise
1Melanoma
Stage III
Stage IV
metastatic
2Skin Cancer
Stage II
Affiliated Hospitals
Clinical Trials Adam Berger is currently running
KHK4951
for Age-Related Macular Degeneration
This trial is testing special eye drops called KHK4951 to help people with a vision problem known as nAMD. The drops aim to improve vision by addressing abnormal blood vessels in the eye.
Recruiting1 award Phase 24 criteria
Neoadjuvant Daromun + Surgery
for Melanoma
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting2 awards Phase 318 criteria
More about Adam Berger
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Adam Berger has experience with
- Aflibercept Injection
- KHK4951
- Panitumumab
- Talimogene Laherparepvec
- Liposomal Annamycin
- IORT With CT-Guided HDR Brachytherapy
Breakdown of trials Adam Berger has run
Melanoma
Skin Cancer
Lung Cancer
Age-Related Macular Degeneration
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Berger specialize in?
Adam Berger focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage III patients, or patients who are Stage IV.
Is Adam Berger currently recruiting for clinical trials?
Yes, Adam Berger is currently recruiting for 4 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Adam Berger has studied deeply?
Yes, Adam Berger has studied treatments such as Aflibercept Injection, KHK4951, Panitumumab.
What is the best way to schedule an appointment with Adam Berger?
Apply for one of the trials that Adam Berger is conducting.
What is the office address of Adam Berger?
The office of Adam Berger is located at: Rutgers Cancer Institute, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.